Cite

HARVARD Citation

    Schneider, H. et al. (2017). Novel TIE‐2 inhibitor BAY‐826 displays in vivo efficacy in experimental syngeneic murine glioma models. Journal of neurochemistry. 140 (1), pp. 170-182. [Online]. 
  
Back to record